Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Paraproteinemia and neuropathy.

Z Simmons1

  • 1Division of Neurology, Penn State University College of Medicine, M.S. Hershey Medical Center, Hershey 17033, USA. zsimmons@psghs.edu

Current Opinion in Neurology
|December 11, 1999
PubMed
Summary

Paraprotein-associated neuropathies are complex neurological disorders with unclear causes. Recent research focuses on understanding their pathogenesis and improving treatments beyond traditional methods, exploring new therapies for better outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effectiveness of non-pharmaceutical interventions as implemented in the UK during the COVID-19 pandemic: a rapid review.

Journal of public health (Oxford, England)·2025
Same author

Non-pharmaceutical interventions to reduce COVID-19 transmission in the UK: a rapid mapping review and interactive evidence gap map.

Journal of public health (Oxford, England)·2024
Same author

The relationship between oestrogen and executive functioning in ALS females with emerging Frontotemporal Lobar Degeneration (FTLD) supports a neuroendocrine model of FTLD attenuation.

Amyotrophic lateral sclerosis & frontotemporal degeneration·2016
Same author

Performance predictors of brain-computer interfaces in patients with amyotrophic lateral sclerosis.

Journal of neural engineering·2016
Same author

Chronic inflammatory demyelinating polyradiculoneuropathy.

Journal of clinical neuromuscular disease·2008
Same author

A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis.

Neurology·2008

Area of Science:

  • Neurology
  • Immunology
  • Pathogenesis research

Background:

  • Paraprotein-associated neuropathies encompass a varied spectrum of neurological conditions.
  • The underlying mechanisms driving these neuropathies are frequently not well-understood.
  • Current treatments include plasma exchange, corticosteroids, and intravenous immunoglobulin, with variable patient responses.

Purpose of the Study:

  • To elucidate the complex pathogenesis of paraprotein-associated neuropathies.
  • To identify novel therapeutic targets and develop more effective treatment strategies.
  • To explore the roles of specific biological factors in disease development.

Main Methods:

  • Review of recent scientific literature on paraprotein-associated neuropathies.

Related Experiment Videos

  • Analysis of emerging factors implicated in disease pathogenesis.
  • Evaluation of the efficacy of established and novel treatment modalities.

    • Main Results:

    • Hepatitis C virus, vascular endothelial growth factor, and cytokines are increasingly recognized as potential contributors to pathogenesis.
    • Established treatments yield inconsistent patient responses.
    • Novel, more aggressive therapies are showing encouraging preliminary results.

    Conclusions:

    • A deeper understanding of pathogenesis is crucial for advancing treatment.
    • Emerging research points to diverse factors influencing neuropathy development.
    • Aggressive therapeutic approaches, including bone marrow transplantation and targeted therapies like Rituximab, offer potential for improved patient outcomes.